A Case of Anaphylactic Response to Factor lX Replacement Therapy in Hemophilia B Patient / 대한혈액학회지
Korean Journal of Hematology
; : 188-190, 2003.
Artigo
em Coreano
| WPRIM (Pacífico Ocidental)
| ID: wpr-720471
Biblioteca responsável:
WPRO
ABSTRACT
We report a first korean case of anaphylactic response to factor lX replacement therapy in 22-month-old male hemophilia B patient. He was admitted to our hospital via emergency room due to anaphylactic response after factor lX infusion. Immediately after the infusion, he became dyspneic and cyanotic. The symptoms completely resolved after sleep. He represented same symptoms after next factor lX infusion, which completely resolved by the administration of oxygen. At the time of anaphylaxis, inhibitors of factor lX was demonstrated(8.8 Bethesda Unit). We planned him to treat with recombinant factor Vll or diluted factor lX at bleeding episode.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Assunto principal:
Oxigênio
/
Hemofilia B
/
Serviço Hospitalar de Emergência
/
Hemofilia A
/
Hemorragia
/
Anafilaxia
Limite:
Humanos
/
Lactente
/
Masculino
Idioma:
Coreano
Revista:
Korean Journal of Hematology
Ano de publicação:
2003
Tipo de documento:
Artigo